Moxetumomab pasudotox and Prochieve
Determining the interaction of Moxetumomab pasudotox and Prochieve and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: progesterone
Brand name: Crinone, Endometrin, FIRST-Progesterone VGS 200, Prochieve, First Progesterone MC10, Menopause Formula Progesterone, Prometrium
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Prochieve (Progesterone Vaginal 4% Gel)
- Moxetumomab pasudotox-Prochieve (Progesterone Vaginal 8% Gel)
- Moxetumomab pasudotox-Prochlorperazine
- Moxetumomab pasudotox-Prochlorperazine Edisylate
- Moxetumomab pasudotox-Prochlorperazine Injection
- Moxetumomab pasudotox-Prochlorperazine Maleate
- Prochieve-Moxetumomab Pasudotox-tdfk
- Prochieve-Moxetumomab pasudotox-tdfk Intravenous
- Prochieve-Moxifloxacin
- Prochieve-Moxifloxacin (Systemic)
- Prochieve-Moxifloxacin Hydrochloride
- Prochieve-Moxifloxacin Injection